This website uses cookies. By continuing you are agreeing to our privacy policy.

Maha Farhat, MD

Research Awards Nationwide Recipient (2013-2015)

Massachusetts General Hospital, Boston, MA
Gene Mutations and Tuberculosis Resistance
Biomedical Research Grant

Anti-tuberculosis (TB) drug resistance is a major public health problem that threatens progress made in TB care and control. Drug resistance in TB is caused by genetic mutations. By investigating the genetic sequences of 28 known and 4 candidate resistant genes for a large panel of TB drugs, Dr. Farhat and team will attempt to determine which mutations predict the extent of resistance, and if specific combinations of mutations interact to affect this resistance level. The information will be used to guide the development of a much needed rapid diagnostic test for drug resistant TB.

Red button with telephone
Ask An Expert

Questions about your lung health? Need help finding healthcare? Call 1-800-LUNGUSA.

Get help
Red button of two hand prints
We need your generous support

Make a difference by delivering research, education and advocacy to those impacted by lung disease.

Button of turquoise LUNG FORCE swirl

LUNG FORCE unites women and their loved ones across the country to stand together in the fight against lung cancer.

Get involved
Join the fight for healthy lungs and healthy air.
Donate Now.